President Donald Trump has announced plans for the administration to take regulatory action targeting pharmaceutical advertising. The initiative involves new rules that will mandate drug manufacturers to include more comprehensive information in their promotional materials. The goal is to improve transparency and ensure that consumers are better informed about the medications they are considering.